Clinical Trials Browser

Phase 1/2 × TNFSF10 protein, human × Clear all

NCT00400764 2011-11-23

A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas

Phase 1/2 Terminated

72 enrolled 20 charts

Lymphoma, Non-Hodgkin